Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4hfn | CIY | 2-alkenal reductase (NADP(+)-dependent) |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4hfn | CIY | 2-alkenal reductase (NADP(+)-dependent) | / | 1.000 | |
| 3p9t | TCL | Repressor | / | 0.485 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.482 | |
| 4kak | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.478 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.473 | |
| 3um5 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.466 | |
| 1xzq | FON | tRNA modification GTPase MnmE | 3.6.5 | 0.465 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.462 | |
| 4i9i | 1DY | Tankyrase-1 | 2.4.2.30 | 0.461 | |
| 4uga | Q05 | Nitric oxide synthase oxygenase | 1.14.13.165 | 0.457 | |
| 2hzq | STR | Apolipoprotein D | / | 0.454 | |
| 2olc | ADP | Methylthioribose kinase | 2.7.1.100 | 0.453 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 4c3y | ANB | 3-ketosteroid dehydrogenase | / | 0.450 | |
| 4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 5ai5 | BSU | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.449 | |
| 1r35 | I58 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.448 | |
| 3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.448 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.448 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.446 | |
| 1s6q | TPB | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 1kyy | INI | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.445 | |
| 2jg7 | NAD | Antiquitin | / | 0.445 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.445 | |
| 3v94 | WYQ | Phosphodiesterase | / | 0.445 | |
| 4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.445 | |
| 4kd7 | 9DR | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.445 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4jda | A9S | Abscisic acid receptor PYL3 | / | 0.444 | |
| 4kfj | 1R0 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
| 3nef | PYV | Abscisic acid receptor PYL1 | / | 0.443 | |
| 4o71 | CPB | Bromodomain-containing protein 4 | / | 0.443 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.442 | |
| 4qoe | FAD | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.442 | |
| 5cc9 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.442 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 2qmy | FAD | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.440 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.440 | |
| 3g5m | FAD | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.440 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.440 | |
| 5d1b | TSN | Histone deacetylase 8 | 3.5.1.98 | 0.440 |